Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
Sign Up to like & getrecommendations! Published in 2020 at "Molecular biology reports"
DOI: 10.1007/s11033-020-05739-2
Abstract: A member of the Trk family of neurotrophin receptors, tropomyosin receptor kinase B (TrkB, encoded by the NTRK2 gene) is an increasingly important target in various cancer types, including glioblastoma (GBM). EGFR is among the… read more here.
Keywords: gbm; inhibition; trkb egfr; expression ... See more keywords